Skip to main content
Clinical Trials/NL-OMON40512
NL-OMON40512
Completed
Phase 2

A combined transvenous and epicardial lead placement procedure for implantation of cardiac resynchronization devices: a feasibility study - Combined transvenous and epicardial lead placement for CRT

niversitair Medisch Centrum Groningen0 sites10 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Heart failure
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
10
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Left ventricular ejection fraction \< 36%.
  • 2\. Intraventricular conduction delay \>119 ms of \>129 ms and presence of left bundle branch block.
  • 3\. On optimal medical therapy for heart failure.
  • 4\. No sidebranch of the coronary sinus near the posterolateral wall of the left ventricle and/or presence of a Thebesian valve which reduces coronary sinus diameter 50% or more (corresponding to a decrease in cross sectional area of 75% or more).
  • 5\. Signed informed consent.

Exclusion Criteria

  • 1\. Previous intrathoracic surgery
  • 2\. Coronary ischemia or recent myocardial infarction (\< 6 months)
  • 3\. Suspected presence of a non\-compliant left lung.

Outcomes

Primary Outcomes

Not specified

Similar Trials